Khorana Risk Score for Thrombosis Prediction in Patients with Gynecologic Malignancies Using Immune Checkpoint Inhibitors- a Real-World Validation

被引：0
|
作者：
Song, Junmin [1 ]
Chang, Yu-Cheng [2 ]
Abram, Ana Maria Diaz [1 ]
Ahn, Jaeun [3 ]
Chi, Kuan-Yu [1 ]
Chang, Yu [4 ]
Chiang, Cho-Han [5 ]
机构：
[1] Albert Einstein Coll Med, Jacobi Med Ctr, Dept Med, Bronx, NY 10461 USA
[2] Danbury Hosp, Dept Med, Danbury, CT USA
[3] Eastern Virginia Med Sch, Dept Internal Med, Norfolk, VA USA
[4] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Surg,Sect Neurosurg, Tainan, Taiwan
[5] Harvard Med Sch, Mt Auburn Hosp, Dept Med, Cambridge, MA USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-212175
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5582 / 5583
页数：2
相关论文
共 50 条
  • [31] Acute kidney injury in patients receiving immune checkpoint inhibitors: a retrospective real-world study
    Lumlertgul, Nuttha
    Vassallo, Pietro
    Tydeman, Florence
    Lewis, Natasha
    Hobill, Abigail
    Weerapolchai, Kittisak
    Nordin, Nurul Zaynah
    Seylanova, Nina
    Martin, Luke
    Cennamo, Armando
    Wang, Yanzhong
    Rigg, Anne
    Shaunak, Nisha
    Ostermann, Marlies
    EUROPEAN JOURNAL OF CANCER, 2023, 191
  • [32] Real-world effectiveness of immune checkpoint inhibitors and BRAF/ MEK inhibitors among veteran patients with cutaneous melanoma
    Kim, Daniel Y.
    Swetter, Susan M.
    Huhmann, Linden
    Dizon, Matthew P.
    Ferguson, Jacqueline M.
    Osborne, Thomas F.
    Spence, Allyson C.
    Ziad, Amina
    Fillmore, Nathanael
    Hartman, Rebecca I.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (03) : 620 - 623
  • [33] Incidence of venous thromboembolism and discriminating capacity of Khorana score in lung cancer patients treated with immune checkpoint inhibitors
    Stancu Alma
    Debourdeau Eloi
    Vazquez Léa
    Coussirou Julie
    Matagne Valérie
    Grassi Pierre
    Werner Hilgers
    Girard Philippe
    Zammit Christine
    Debourdeau Philippe
    Journal of Thrombosis and Thrombolysis, 2022, 54 : 287 - 294
  • [34] Assessment of Risk-Benefit Balance of Immune Checkpoint Inhibitors in a Real-World Lung Cancer Population
    Mehta, Hemalkumar B.
    Segal, Jodi
    Heyward, James
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 167 - 168
  • [35] Incidence of venous thromboembolism and discriminating capacity of Khorana score in lung cancer patients treated with immune checkpoint inhibitors
    Alma, Stancu
    Eloi, Debourdeau
    Lea, Vazquez
    Julie, Coussirou
    Valerie, Matagne
    Pierre, Grassi
    Hilgers, Werner
    Philippe, Girard
    Christine, Zammit
    Philippe, Debourdeau
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 54 (02) : 287 - 294
  • [36] Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data
    Toribio-Garcia, Irene
    Olivares-Hernandez, Alejandro
    Miramontes-Gonzalez, Jose Pablo
    Dominguez, Luis Posado
    Garcia, Ana Martin
    Bachiller, Rocio Eiros
    Figuero-Perez, Luis
    Martinez, Maria Garijo
    Ruiz, Jonnathan Roldan
    Hernandez, Lorena Bellido
    Fonseca-Sanchez, Emilio
    Sanchez, Pedro Luis
    del Barco-Morillo, Edel
    CANCERS, 2023, 15 (17)
  • [37] A real-world data of Immune checkpoint inhibitors in solid tumors from India
    Noronha, Vanita
    Abraham, George
    Patil, Vijay
    Joshi, Amit
    Menon, Nandini
    Mahajan, Abhishek
    Janu, Amit
    Jain, Srushti
    Talreja, Vikas T.
    Kapoor, Akhil
    Singh, Gunjesh Kumar
    Khaddar, Satvik
    Gupta, Kushal
    Rathinasamy, Narmadha
    Srinivas, Sujay
    Agrawal, Amit
    Ventrapati, Pradeep
    Prabhash, Kumar
    CANCER MEDICINE, 2021, 10 (05): : 1525 - 1534
  • [38] Real-world use of immune checkpoint inhibitors in advanced or recurrent endometrial cancer
    Huepenbecker, Sarah
    Meyer, Larissa A.
    Craft, Miranda
    Chan, John K.
    Craggs, Christopher
    Lambert, Peter
    Lin, Yvonne G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, : 1719 - 1728
  • [39] EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN GLIOBLASTOMA FROM REAL-WORLD DATA ANALYSIS
    Stuhlmiller, Timothy
    Quinn, Jameson
    Awawda, Alaa
    Blondin, Nicolas
    Iwamoto, Fabio
    Nabors, Burt
    Redfern, Charles
    Wasserman, Asher
    Cole, Zachariah
    Shapiro, Mark
    Kesari, Santosh
    NEURO-ONCOLOGY, 2023, 25
  • [40] The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors
    Eljilany, Islam
    Saghand, Payman Ghasemi
    Chen, James
    Ratan, Aakrosh
    McCarter, Martin
    Carpten, John
    Colman, Howard
    Ikeguchi, Alexandra P.
    Puzanov, Igor
    Arnold, Susanne
    Churchman, Michelle
    Hwu, Patrick
    Conejo-Garcia, Jose
    Dalton, William S.
    Weiner, George J.
    El Naqa, Issam M.
    Tarhini, Ahmad A.
    CANCERS, 2023, 15 (20)
12345